The use of a laboratory school protocol to evaluate concepts about efficacy and side effects of new formulations of stimulant medications.

@article{Swanson2002TheUO,
  title={The use of a laboratory school protocol to evaluate concepts about efficacy and side effects of new formulations of stimulant medications.},
  author={James M. Swanson and Marc A Lerner and Timothy L Wigal and Ken Steinhoff and Laurence I Greenhill and Kelly L Posner and J Freid and Sharon B. Wigal},
  journal={Journal of attention disorders},
  year={2002},
  volume={6 Suppl 1},
  pages={S73-88}
}
Recently, new long-acting formulations of racemic methylphenidate (MPH: Ritalin LA, Metadate CD and Concerta) and amphetamine (AMP: Adderall XR) were developed and are now approved by the Food and Drug Administration (FDA). In addition, dexmethylphenidate (Focalin), the pharmacologically active d-threo enantiomer of MPH, also was approved by the FDA. In the initial phases of development, prototypes of these five new formulations were evaluated using the University of California, Irvine (UCI… CONTINUE READING
Highly Influential
This paper has highly influenced 16 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
33 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 33 extracted citations

Similar Papers

Loading similar papers…